Human parturition is an inflammatory event, modulated and influenced by a host of other environmental and physiological processes, including the endocrine hormones.
Introduction
Human pregnancy and labour are extraordinary physiological events during which the fetal allograft must first be tolerated, nourished, allowed to develop and (when it is developmentally mature enough to survive the outside world), the process of labour mounted to deliver the fetus from the mother's body. This process of human labour is an elegantly choreographed sequence of events including the remodelling and dilatation of the cervix, rupture of the fetal membranes and the onset and maintenance A c c e p t e d M a n u s c r i p t of effective uterine contractions, culminating in expulsion of the fetus and placenta. The entire process is followed by involution of the uterus. However, although some aspects of human parturition are reasonably well understood, the complexity of interactions between different systems and tissues, together with the well-documented inter-species differences that are observed, combine to ensure that a complete understanding of what initiates labour, or how it is propagated and controlled, has not yet been achieved. The importance of achieving such an understanding is, of course, so that we may be able to develop strategies to improve outcomes for women and their infants for whom the process, or its timing, becomes abnormal.
Preterm birth is the major cause of neonatal mortality and morbidity in developed countries (Norman et al., 2009b ) with a rising prevalence currently of 7.6% in Scotland (Norman et al., 2009b) and 9.6% of births worldwide (March of Dimes, 2009 , Martin et al., 2006 . Preterm labour (with or without preterm premature membrane rupture) is the cause of preterm birth in around 75% of women (Norman et al., 2009b) . Its causes are multifactorial, with infection implicated as a major cause, although the majority of preterm births are idiopathic (Goldenberg et al., 2008 , Norman et al., 2009b . In contrast, dysfunctional or delayed parturition at term may also cause significant complications including caesarean section, for which the rate is rising having increased from 9% in 1980 in England and Wales to 21% in 2001 (Thomas, 2001) . Thus a better understanding of the physiological processes of normal and abnormal parturition may help us to develop strategies to treat these pathologies and reduce both maternal and neonatal mortality and morbidity.
Traditional concepts of parturition, and indeed the hypothesis for which there is most evidence in animals, suggest that labour is a hormonal event, driven primarily by changes in progesterone and/or cortisol synthesis. Such a model can be applied to human parturition, but fits less well. Over the last 10 years, we and others have proposed that the primary events in human parturition are inflammatory, with hormonal changes being secondary or complementary. The purpose of this review is to highlight the evidence for each model separately, and then to consider which of these events is likely to be pre-eminent.
Labour as an inflammatory event
Page 4 of 24 A c c e p t e d M a n u s c r i p t It is not a new observation that human parturition is an inflammatory event, but in recent years there have been many exciting new developments that have helped this concept to strengthen and evolve. At its most basic level, this concept is supported by the demonstration that leukocytes, (largely neutrophils and macrophages, and also T cells) invade the myometrium, cervix and fetal membranes at or immediately after the onset of labour (Osman et al., 2003 , Thomson et al., 1999 , attracted by increased tissue expression of chemokines and cell adhesion molecules (Ledingham et al., 2001 , Winkler et al., 1998 . In parallel, leukocytes circulating in the peripheral blood increase their expression of cell adhesion molecule ligands such as CD11a and CD11b (Yuan et al., 2009) , facilitating leukocyte emigration into the myometrium and cervix.
The increased expression of cytokines in the myometrium and cervix in labour (Osman et al., 2003) arises in part from the invading leukocytes (Young et al., 2002) with recent evidence suggesting that increased capacity of leukocytes in labour to express cytokines is initiated in the peripheral circulation (Yuan et al., 2009 ). These pro-inflammatory cytokines have a multitude of effects on the reproductive tissues, including stimulatory effects on myometrial contractility via a number of different mechanisms, discussed below. Cytokines are also involved in tissue remodelling (Sennstrom et al., 2000) and attract more leukocytes in a positive feedback mechanism (Elliott et al., 2000) , augmenting the process of parturition. The activity of nuclear factor-kappa B (NF-κB), a transcription factor regulating numerous genes involved in a multitude of cellular processes including inflammation, is also increased in labour ). The most clearly described increase in NF-κB in association with parturition occurs in the fetal membranes , although NF-κB is also expressed in the myometrium with obvious changes being described in pregnancy (Chapman et al., 2004) . NF-κB may provide a feed forward mechanism for inflammatory processes in labour, given that it is itself highly inducible by pro-inflammatory stimuli (Belt et al., 1999 , Kniss et al., 2001 , Lappas et al., 2002 .
Taken together therefore, labour is associated with leukocyte invasion, NF-κB activation and pro-inflammatory cytokine production in some if not all of the relevant reproductive tissues. These data strongly support the hypothesis that labour is an A c c e p t e d M a n u s c r i p t inflammatory event. The functional effects of these pro-inflammatory events are described below.
Myometrium
The upregulation of pro-inflammatory cytokines within labouring myometrium stimulates and potentiates uterine contractions. Tribe et al have demonstrated that interleukin (IL)-1β induces basal and store operated calcium entry in myometrial smooth muscle cells, thus directly increasing their contractile potential (Tribe et al., 2003) . Additionally, IL-1β and tumor necrosis factor (TNF)-α stimulate arachidonic acid release, and expression of cyclooxygenase (COX)-2 thus increasing prostaglandin production in myometrial cell cultures, via greater NF-κB activity (Belt et al., 1999 , Rauk and Chiao, 2000 .
Prostaglandins have long been known as stimulators of myometrial contractions (Johnston et al., 1993) thus there is a clear potential causal link between the inflammatory events observed in the myometrium and the clinical process of parturition.
The cervix
Cervical ripening is characterised by breakdown of collagen and remodelling of the connective tissue element of the cervix. Leukocyte invasion and the increase in protein concentrations of IL-8, IL-6 and granulocyte-CSF (G-CSF) observed in the human cervical connective tissue at term and subsequently in labour are likely to be crucial to the process of cervical remodelling to facilitate opening during parturition (Osman et al., 2003 , Sennstrom et al., 2000 . Functionally, IL-8 may stimulate the release of degradative enzymes from neutrophils. These enzymes include serine proteases and matrix metalloproteinases ((MMP)-8 and MMP-9)) (Kelly, 2002) which then participate in degradation of the collagen and glycosaminoglycan components of the extracellular matrix thereby leading to cervical ripening (Hertelendy and Zakar, 2004) . Production of MMP-1, MMP-3 and MMP-9 from resident fibroblasts (Ito et al., 1991) and smooth muscle cells (Watari et al., 1999) may also be increased by IL-1β in the cervix whilst downregulating the expression of tissue inhibitor of metalloproteinase (TIMP)-2, an endogenous inhibitor of MMP-2 (Watari et al., 1999) , with these events being further amplified by NF-κB production. NF-κB itself may be A c c e p t e d M a n u s c r i p t activated via toll-like receptor (TLR)-4 by degraded extracellular matrix proteins such as fragments of fetal fibronectin, degraded during cervical remodelling, thus reinforcing the ongoing sterile inflammation of labour (Challis et al., 2009) . Thus, at the end of pregnancy and during labour, the cervix having remained firm and closed despite increasing pressure during pregnancy, begins, under the influence of a host of inflammatory mediators, to soften and dilate.
Fetal membranes
A similar pro-inflammatory pattern to that observed in the myometrium is seen in the fetal membranes. The production of IL-8, TNF-α, IL-6 and IL-1β are all increased in the fetal membranes and amniotic fluid during labour (Young et al., 2002) . There are also increased levels of MMP-9 (Vadillo-Ortega et al., 1995) and decreased levels of the TIMPs (Riley et al., 1999) . Functionally, an increased MMP /TIMP ratio weakens the fetal membranes, facilitating fetal membrane rupture which is often the precursor to labour.
Careful examination of the fetal membranes from pre-labour specimens obtained at caesarean section has demonstrated that a zone of weakness exists in the region overlying the cervix (McLaren et al., 1999) . The features of this zone include a decrease in thickness in comparison to the rest of the fetal membranes, increased MMP-9 and decreased TIMP-3 and also increased poly (ADP-ribose) polymerase -1 (PARP1) cleavage (El Khwad et al., 2005) . PARP1 is an enzyme involved in DNA repair and apoptosis and thus its increase indicates increased apoptosis (El Khwad et al., 2005) . It would seem therefore that towards the end of pregnancy the fetal membranes are prepared for labour by a process of remodelling to develop a weakened area that is the site of rupture. What initiates and develops this process is not known but a greater understanding of the molecular events leading to membrane rupture may lead to developing novel therapeutic strategies to halt its premature onset in preterm labour.
The fetal membranes are specifically important, as they are the interface between the fetus and the mother, and may transmit pro-labour signals from the baby to the A c c e p t e d M a n u s c r i p t mother's myometrium and cervix. Pulmonary derived surfactant proteins and phospholipids may be key to this: as the fetus matures, increased quantities are produced and so levels increase in the amniotic fluid. These surfactant proteins may well contribute to the inflammatory response that can be observed in the fetal membranes and in the underlying cervix and myometrium (Smith, 2007) given that they stimulate COX-2 activity via TLR-4 in mice (Wang and Hirsch, 2003) and subsequent prostaglandin E2 (PGE2) production in the amnion. Increased PGE2 production in the amnion could diffuse through the chorion and decidua to stimulate myometrial cell prostaglandin production and hence contractility (Slater et al., 1999 , Smith, 2007 . The fetus and placenta may also jointly trigger fetal membrane rupture, since prostaglandins, TNF-α and corticotrophin releasing hormone (CRH) (which also rise in the amniotic fluid towards term (Alvi et al., 1999 , Laatikainen et al., 1988 ) all stimulate the production of MMP-9, which weakens the membranes and thus facilitates membrane rupture (Kumar et al., 2006 , Young et al., 2002 .
Preterm Birth and Inflammation
Preterm labour may be initiated by a multitude of different mechanisms, including infection, placental haemorrhage, cervical insufficiency, and uterine over-distention.
The cause is multi-factorial and is often idiopathic; however, infection is the single biggest aetiological factor (Goldenberg et al., 2008) . Micro-organisms such as Escherichia coli, Ureaplasma urealyticum and Streptococcus agalatae are receognised by the TLRs, which stimulate increased production of inflammatory cytokines at least in part by NF-κB and initiate the cascade of inflammatory events described above, resulting in preterm parturition (Peltier, 2003) .
Several animal models of parturition involve stimulation with pro-inflammatory substances such as lipopolysaccharide (LPS) to mimic the onset of preterm labour (Elovitz et al., 2003 , Fidel et al., 1994 . Such animal models have helped to develop potential new strategies for treating preterm birth. The importance of inflammation is demonstrated by experiments showing that the anti-inflammatory agent IL-10 not only prevents preterm birth, but also prevents neonatal brain damage in rats (RodtsPalenik et al., 2004 , Terrone et al., 2001 ). More recently, Bennett's group have shown A c c e p t e d M a n u s c r i p t that the anti-inflammatory prostaglandin 15-deoxy-delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) may have similar dual effects: in their mouse model 15d-PGJ (2) inhibited both LPS induced contractions and preterm delivery and the upregulation of NF-κB in the fetal brain (Pirianov et al., 2009) . These results encourage the possibility of the future development of agents that could be used not only to prevent preterm labour but also to protect the developing fetus from the damaging effects of surrounding inflammation.
Labour as an endocrine event

Progesterone
Progesterone sustains the state of pregnancy and maintains uterine quiescence throughout gestation. It has long been observed that in most mammalian species a fall in plasma levels of progesterone is the initiating step towards parturition. However, contrary to what is observed in other mammalian species, most human studies have demonstrated that progesterone levels in pregnancy remain constant in plasma in the late third trimester of pregnancy and during labour (Boroditsky et al., 1978 , Mathur et al., 1980 The fact that the progesterone receptor antagonist mifepristone is an effective agent for induction of labour to soften the cervix and increase uterine sensitivity to uterotonic agents (Hapangama and Neilson, 2009 ) does suggest that a role exists for some form of progesterone withdrawal being involved in the initiation of human parturition. An alternative concept of 'functional progesterone withdrawal' has therefore been proposed for humans, in which there is loss of the quiescent effect of progesterone on myometrium, despite continuing high systemic and local levels.
There have been several different mechanisms proposed for this, including local metabolism of progesterone (Mitchell and Wong, 1993) , changes in ratios of the progesterone receptor isoforms (Mesiano et al., 2002) and changes in levels of cofactors affecting progesterone receptor (PR) function (Condon et al., 2003) .
Progesterone can be metabolised to a less active metabolite, 20α-dihydroprogesterone and it has been shown that production of this less active form increases after the initiation of labour (Mitchell and Wong, 1993) , presenting a potential mechanism for functional progesterone withdrawal. Functional progesterone withdrawal also likely occurs at the receptor level -either via changes in progesterone receptor isoforms or 
Estrogen
Estrogen has a stimulatory effect on contractions of human myometrium, by increasing the expression of uterine contraction associated protein (CAP)-genes such as connexin-43 and oxytocin receptors. Here again, the contrast exists between the human and other mammalian species in that in most mammals parturition is associated with an increase in circulating estrogens, but in humans, serum estrogen levels are high throughout pregnancy, gradually increasing to term (Tulchinsky et al., 1972 ). This increase is accelerated in the final few weeks of pregnancy but there are no significant difference in estrogen levels during labour compared to just before labour (Boroditsky et al., 1978 , Turnbull et al., 1974 . mRNA expression of the estrogen receptor (ER)-α is increased in labouring myometrium, suggesting that a functional estrogen activation may also occur, which has been linked to the functional progesterone withdrawal (Mesiano et al., 2002) . Recent data from Smith and colleagues suggests that a change in estradiol/estriol ratios and progesterone to estriol ratio might be important, and that hormone trajectories in the individual may have greater impact than absolute levels. (Smith et al., 2009) .
A c c e p t e d M a n u s c r i p t
Corticotropin-releasing hormone and the "placental clock"
Corticotropin-releasing hormone is a 41-amino acid peptide released from the hypothalamus and it regulates the hypothalamic-pituitary-adrenal (HPA) axis and plays a central role in the response to stress (Wadhwa et al., 2001) . In human pregnancy, the placenta releases CRH and maternal plasma CRH levels increase exponentially, peaking at delivery, and returning to pre-pregnancy levels within 24 hours of birth (Campbell et al., 1987 , Kalantaridou et al., 2004 . Interestingly, placental production of CRH seems to occur only in primate species, again reinforcing the uniqueness of human parturition (Robinson et al., 1989) . CRH binding protein (CRH-BP) produced by the liver and placenta, limits the bioavailability of CRH but its levels fall during the last six weeks of pregnancy leaving increased levels of free CRH (Linton et al., 1993) . Women in preterm labour have significantly elevated levels of CRH compared to non-labouring women of the same gestation, a finding that can also be seen several weeks in advance of clinical signs of preterm labour (McLean et al., 1995 , Wadhwa et al., 1998 . Taken together, these observations form the hypothesis that CRH may function as a placental clock in humans, determining the length of gestation and onset of labour (McLean et al., 1995) . A positive feedback loop has been proposed whereby fetal glucocorticoids, produced by the maturing fetal adrenal glands, promote placental CRH gene expression and CRH production, which in turn stimulates further fetal cortisol production via the HPA axis (Robinson et al., 1988) . This system may also be modulated by maternal or fetal stress, which has been suggested as a possible mechanism for the increased rates of preterm delivery observed in women suffering from increased levels of stress (Wadhwa et al., 2001) .
The contribution that these increasing levels of CRH may have on parturition itself is not yet certain. CRH signals through G protein-coupled receptors which exist in several different forms and use different second messenger systems to exert their effects (Grammatopoulos et al., 1995) . During pregnancy the predominant CRH receptor in the myometrium is CRH receptor (R)1α, binding of which by CRH promotes myometrial relaxation via activation of cAMP (Grammatopoulos et al., 1994) . However, this action is inconsistent with the concept of CRH functioning as a 'placental clock' and promoting labour. At term, the affinity of CRH for its receptor is M a n u s c r i p t reduced, and oxytocin has been implicated in promoting this reduction by inhibiting the activity of adenylate cyclase (Grammatopoulos and Hillhouse, 1999b) . Thus it has been hypothesised that CRH may be involved in promoting contractile activity via its interaction with oxytocin (Grammatopoulos and Hillhouse, 1999a) .
Oxytocin
Oxytocin and its receptor (OT and OTR) play an important role in parturition, although their precise role is as yet incompletely understood . Plasma concentrations of OT rise with labour (Thornton et al., 1992) , as do concentrations of OT in gestational tissues . Clinically, synthetic oxytocin is used to augment contractions during dystocic labour and OTR antagonists are licensed as tocolytic agents for the treatment of preterm labour (Romero et al., 2000) . However, OT appears not to be an essential participant in labour as oxytocin (-/-) null mice can deliver normally (Nishimori et al., 1996 . The oxytocin receptor increases at term in myometrial tissue (Fuchs et al., 1984) and its increased expression leads to direct contractile effects in myometrium .
Preterm birth and the Endocrine System
Progesterone supplementation has been used for many decades now to try to prevent preterm labour and reduce the severity of its neonatal sequelae (Fuchs and Stakemann, 1960) . Three large randomised controlled trials have suggested that administration of progesterone reduces the risk of preterm delivery in high-risk singleton pregnancies (da Fonseca et al., 2003 , Fonseca et al., 2007 , Meis et al., 2003 . Importantly, this effect appears to be confined to singleton pregnancies for reasons that are as yet unclear (Norman et al., 2009a, Simhan and Caritis, 2007) .
Currently, the reduction in preterm delivery achieved by progesterone has not been shown to be accompanied by an improvement in perinatal mortality (Dodd et al., 2008) and further studies are ongoing to explore long-term outcomes in infants whose mothers are treated antenatally with progesterone to prevent preterm delivery.
Human labour is an immune not an endocrine event M a n u s c r i p t So if the onset of human labour has features of inflammation and endocrine changes, which is the predominant? There is little compelling evidence to suggest that in humans a hormonal switch exists that signals the end of pregnancy and begins the process of parturition. Unlike most animal species studied, humans do not appear to be dependent on the withdrawal of progesterone, nor on an increase in estrogen for labour to commence. Rather, it seems that a multitude of complex and interlinked processes combine to overwhelm the quiescent phase of pregnancy and initiate labour.
Mitchell and Taggart have suggested a model of 'modular accumulation of physiological systems' in which multiple interlinking physiological processes develop in parallel until a critical mass is achieved which results in parturition (Mitchell and Taggart, 2009) . Their model also describes how the premature and inappropriate activation of some of the 'modules' could result in preterm labour thus such a concept could explain the onset of both term and preterm human labour. We propose that the linkages between such processes are dominated by the inflammatory system and that whilst hormones play an undoubtedly vital part in human parturition, it is the immune system that is the more important driving force. Progesterone has long been described as an 'anti-inflammatory steroid' and this is supported by a wealth of data demonstrating its interactions with the immune system. Progesterone itself inhibits IL-6 production in fetoplacental arteries (Gotkin et al., 2006) , and progestogens such as medroxyprogesterone acetate inhibit a range of proinflammatory cytokines and chemokines in human myometrium (Shynlova et al., 2008 , Youssef et al., 2009 . Of particular interest are the interactions of progesterone with NF-κB, a transcription factor which has key functions within human parturition , Elliott et al., 2001 . NF-κB activation increases in fetal membranes in labour ) but is negatively repressed by activation of the progesterone receptor . In contrast, NF-κB itself represses progesterone receptor activity; work from Carole Mendelson's group has demonstrated that activation of NF-κB in human myometrium upregulates inhibitory PR isoforms (Condon et al., 2006) . It may be that the removal of the immunosuppressive, quiescent influences of progesterone by the functional progesterone withdrawal may in fact itself be initiated by inflammation and activation of NF-κB (see Fig1).
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A c c e p t e d M a n u s c r i p t Estrogens can induce either proinflammatory or anti-inflammatory effects, depending on the immune stimuli, the cell types involved, the target organ, estrogen concentration and receptor expression (Straub, 2007) . With respect to cytokine expression, estrogen in the high concentrations seen in pregnancy can inhibit proinflammatory pathways which include those activated by IL-1β (Polan et al., 1989) , IL-6 (Keck et al., 1998 , Kikuchi et al., 2000 , IL-8 (Rodriguez et al., 2002) and TNF-α (Rogers and Eastell, 2001) as well as inhibiting the activity of natural killer cells (Seaman and Gindhart, 1979) . In contrast, the secretion of 'anti-inflammatory interleukins' IL-4 (Kamada et al., 2001) , IL-10 (Kanda and Tamaki, 1999) and transforming growth factor (TGF)-β (Hatthachote and Gillespie, 1999) are stimulated by estrogen in these high levels. Notwithstanding these clear anti-inflammatory effects of estrogen, in vivo estradiol can augment the production of pro-inflammatory cytokines by CD4+ T cells (Maret et al., 2003) likely via a direct effect as circulating leukocytes express ER-α (Straub, 2007) . Thus, although estrogen has a stimulatory effect on myometrium, it also has highly complex interactions with the immune system that may contribute to the quiescence maintained throughout pregnancy.
CRH and the HPA axis are intimately linked with the immune system and exert complex effects on the human female reproductive system (Kalantaridou et al., 2004) .
CRH has been shown to regulate cytokine production, and in return inflammatory cytokines influence CRH production. For example both TNF-α and IL-1β stimulate production of CRH (Dudley, 1999) and conversely CRH inhibits the production of IL-1 and IL-6 by peripheral blood mononuclear cells (Salas et al., 1997) . CRH may reduce the cytotoxicity of natural killer cells (Irwin et al., 1990) and also inhibits T cell proliferation (Jain et al., 1991) . Increasing fetal cortisol production, perpetuated by increasing CRH production as described above, is also associated with fetal lung maturation and production of surfactant proteins and phospholipids which are present in the amniotic fluid. Such compounds are proinflammatory and it has been proposed (Smith 2007 ) that they might stimulate production of prostaglandins and initiation of inflammation in the fetal membranes.
The effect of inflammatory cytokines on the OTR is somewhat conflicting as described in the literature. Schmid et al reported a downregulation of OTR mRNA by IL-1β in a myometrial cell line (Schmid et al., 2001) , and Rauk et al also reported M a n u s c r i p t down-regulation of OTR mRNA following treatment with IL-1β and up-regulation after treatment with IL-6 in primary human smooth muscle cells FriebeHoffmann, 2000, Rauk et al., 2001 (Terzidou et al., 2006) which is more consistent with the actual mileu present in labour i.e. increased levels of IL-1β, COX-2 and IL-8. The OTR promoter contains putative transcription binding sites for CCAAT/enhancer binding protein (C/EBP) and NF-κB, which are transcription factors activated by cytokines such as IL-1β and IL-6 (Terzidou et al., 2006) . IL-1β and IL-6 increase the secretion of oxytocin in uterine smooth muscle cells ) and IL-1β has been observed to augment the oxytocin-stimulated contractility of myometrial strips in culture . Thus, it seems likely that the result of the infiltration of inflammatory cells and increase in pro-inflammatory cytokines is to activate the myometrial tissue (at least in part via an increase in OTR expression) and to promote contractility.
Strategies to treat preterm birth
As knowledge accumulates about the mechanisms of preterm and term human labour, we can hope to come closer to an effective therapy for preventing preterm or dysfunctional labour. As described earlier, investigators have seen promising results in animal models with anti-inflammatory agents, although neither IL-10 nor 15d-PGJ(2) are yet available for clinical use. Data from other animal models suggesting that progestogens may protect against traumatic and ischaemic induced brain injury (at least partly due to their inhibitory effect on pro-inflammatory cytokine production is also highly encouraging (Sayeed and Stein, 2009) . Ultimately, there is still much work to be done before the mysteries of human parturition are revealed. Although we believe that the inflammatory reaction that accompanies labour is essentially the orchestrating force that drives it (Fig 2) , many fascinating questions remain to be explored before this theory can be proven. Inflammation in response to intrauterine infection is an important cause of many, but not all, cases of preterm labour. How do the inflammatory signatures of infected and non-infected term and pre-term labour compare and how may this clarify potential initiators of labour? Recently published M a n u s c r i p t gene-profiling work by Weiner et al has suggested that indeed there may be differences in the initiating pathways between term and preterm labour, which will no doubt provoke further exploration of these differences.
Conclusions
The biochemical mechanisms of human parturition in which the membranes weaken and rupture, the cervix softens and effaces and the uterus is activated to produce contractions, are both highly complicated and incompletely understood. It is clear that an intricate web of interactions exists between components of the endocrine and immune systems in order to regulate this process, and that disorders within it may lead to significant complications for both mother and infant. We propose that the farreaching influences of the inflammation of labour may prove to be the key to unlocking the secrets behind human parturition and that further elucidation of these interactions between the immune and endocrine systems will help to develop strategies to treat the complications of labour that women still face. M a n u s c r i p t A c c e p t e d M a n u s c r i p 
